• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Blood test for free tumour DNA could guide breast cancer therapy

  • — 3 Apr, 2013

CAMBRIDGE, UK—A new blood test promises quicker assessment of treatment efficacy in patients with metastatic breast cancer. Dr Dana Tsui and colleagues from the Cancer Research UK Cambridge Institute, University of Cambridge, report in the New England Journal of Medicine that circulating tumour DNA is a more powerful marker of breast cancer progression than using blood tests for cancer cells or antigens, and raises the possibility of screening the effectiveness of drugs in days rather than months needed to wait for a change in radiological appearance.

You may also like...

  • Big steps forward for advanced melanoma treatment Big steps forward for advanced melanoma treatment 10 Oct, 2013
  • Audio Journal of Oncology in Advance – January 1st, 2007 – Reporting from San Antonio Breast Cancer Symposium, December 14-17, 2006 Audio Journal of Oncology in Advance – January 1st, 2007 – Reporting from San Antonio Breast Cancer Symposium, December 14-17, 2006 2 Jan, 2007
  • ASCO Audio Journal of Oncology in Advance – February 15th, 2007 – reporting from San Antonio Breast Cancer Symposium, December 13-17, 2007 ASCO Audio Journal of Oncology in Advance – February 15th, 2007 – reporting from San Antonio Breast Cancer Symposium, December 13-17, 2007 16 Feb, 2007
  • Complexity And Lack Of Independence — Hazards For Humanitarian Organisations Intervening In Disasters Complexity And Lack Of Independence — Hazards For Humanitarian Organisations Intervening In Disasters 21 Jun, 2011
  • Previous story Circulating free tumour DNA test could guide breast cancer therapy
  • Next story Two-step immunotherapy brings promise in advanced ovarian cancer
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second…
    • Volume CT Lung Cancer Screening Cuts Cancer Deaths 24 Per…
    • Microbiome Diversity Key To Survival After Allogeneic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
  • Home
  • Oncology
  • Blood test for free tumour DNA could guide breast cancer therapy

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.